Información de la revista
Vol. 14. Núm. 2.
Páginas 108-109 (enero 2002)
Vol. 14. Núm. 2.
Páginas 108-109 (enero 2002)
Acceso a texto completo
Determinación de la proteína C reactiva para indicar el tratamiento con estatinas en la prevención primaria de los acontecimientos coronarios agudos
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
Visitas
1105
F. Fabiani
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.M. Ridker, C.H. Hennekens, J.E. Buring, N. Rifai.
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
N Engl J Med, 342 (2000), pp. 836-843
[2.]
W. Koenig, M. Sund, M. Frohlich, et al.
C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-age men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.
Circulation, 99 (1999), pp. 237-242
[3.]
J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, et al.
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.
BMJ, 321 (2000), pp. 199-204
[4.]
P.M. Ridker, N. Rifai, S.P. Lowenthal.
Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia.
Circulation, 103 (2001), pp. 1191-1193
[6.]
A.M. Garber.
Using cost-effectiveness analysis to target cholesterol reduction.
Ann Intern Med, 132 (2000), pp. 833-835
[7.]
C.P. Sparrow, C.A. Burton, M. Hernández, S. Murd, H. Hassing, S. Patel, et al.
Simvastatin has antiinflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering.
Arterioscler Thromb Vasc Biol, 103;21 (2001), pp. 115-121
[8.]
J.J. Escolar Castellón.
Isoprenoides, inflamación y aterosclerosis.
Clin Invest Arterioscl, 12 (2000), pp. 167-170
[9.]
I. Jialal, D. Stein, D. Balis, S.M. Grundy, B. Adams-Huet, S. Devaraj.
Effect of hydroxymethyl glutaryl coenzyme A reductasa inhibitor therapy on high sensitive C-reactive protein levels.
Circulation, 103 (2001), pp. 1933-1935
Copyright © 2002. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.